From the Departments ofPathology, John Radcliffe Hospital, Headington, Oxford, and *the Bristol Royal Infirmary, Bristol SUMMARY The distribution of fibronectin and laminin was examined by immunohistochemistry in 11 adenoid cystic breast carcinomas, six adenoid cystic carcinomas of mouth and salivary gland, and six cribriform ductal breast carcinomas. Both proteins were present lining cystic lumina and around tumour islands in all the adenoid cystic breast carcinomas and in five of six salivary gland tumours. Abundant laminin and fibronectin were dispersed among adenoid cystic tumour cells arranged in sheets. One adenoid cystic carcinoma from buccal mucosa showed a transition from a cribriform tumour positive for both fibronectin and laminin to a cribriform tumour negative for fibronectin and laminin to undifferentiated carcinoma. Fibronectin and laminin seemed to disappear simultaneously from tumour cell surfaces. Another adenoid cystic carcinoma from buccal mucosa was negative for fibronectin and laminin from the time of initial biopsy. This was the only tumour that gave rise to disseminated metastases, resulting in the death of the patient within two years of surgery. In cribriform invasive ductal breast carcinomas the linings of cystic lumina were always negative for fibronectin and laminin. Varying quantities were present at the tumour boundaries. We suggest that staining for fibronectin and laminin may be a valuable aid to the diagnosis of adenoid cystic carcinomas and that the absence of these proteins may have important prognostic implications.
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Adenoid cystic carcinomas are tumours which arise most often in the mouth and salivary glands, but which may also occur in other sites-namely, the tracheobronchial tree, nasopharynx, maxillary sinus, uterine cervix, skin and breast. '`5 Fibronectin and laminin are both non-collagenous glycoproteins associated with basal lamina. '2 13 Fibronectin is also found in interstitial connective tissue and in extracellular body fluids.'4 Ultrastructural immunohistochemistry has localised laminin to both the lamina rara and lamina densa of basement membranes'5 16; the precise localisation of fibronectin is more controversial. 14 17 -19 A previous study showed the presence of fibronectin lining the cystic spaces of an adenoid cystic carcinoma of the submandibular salivary gland.20 In this study we compared the distribution of fibronectin and laminin in a series of adenoid cystic carcinomas from breast with their distribution in cribriform ductal carcinomas of breast and in adenoid cystic carcinomas of the mouth and salivary gland. The aim was to determine whether staining for fibronectin and laminin may be of value in diagnosing these tumours and whether the presence of these proteins has any prognostic implications.
Material and methods
Tissue was examined from eleven adenoid cystic 138 Table I summarises the clinical details of these cases. Four of the six tumours (cases 1-4) showed strong positive staining for fibronectin and laminin along cell boundaries both within and at the periphery of tumour islands. The immunostaining was seen lining pseudocysts, along the margins of epithelial cell cords, and abundantly between those tumour cells which were arranged in sheets ( Fig. 1 ). This staining pattern was present in local recurrences as well as in the initial tumour. Only one case (2) showed focal cytoplasmic staining for laminin (Fig. 2) . No intracellular fibronectin was shown. In case 5 there was a transition from typical adenoid cystic carcinoma to a poorly differentiated carcinoma with a focally squamoid appearance. In one part of the tumour fibronectin and laminin were present lining pseudocystic lumina and peripherally around individual islands of carcinoma cells. Adjacent tumour cells showed retention of the classical cribriform pattern but loss of fibronectin and laminin (Fig. 3) . Staining consecutive serial sections for both these proteins suggested that they were lost simultaneously, initially from the pseudocystic spaces and subsequently from the tumour boundaries. The cribriform tumour negative for fibronectin and laminin merged into a poorly differentiated carcinoma in which laminin staining was discontinuous and irregular at the margins, or was completely absent. Fibronectin showed a similar distribution but was found in increased amounts in the tumour stroma. Case 6 was a carcinoma of cribriform appearance in which cystic lumina were negative for both fibronectin and laminin from the time of initial biopsy. Scanty and fragmented laminin was evident at some tumour boundaries but most were negative. Parts of the tumour were less well differentiated and these showed increased stromal fibronectin. Table 2 summarises the clinical details of these cases. Fibronectin and laminin were seen lining pseudocystic spaces within all these tumours (Fig. 4) . Where tumour cells were arranged in sheets fibronectin and laminin were dispersed irregularly among them and sometimes outlined small pseudocysts that were not otherwise readily detectable. Only one case showed focal intracytoplasmic staining for laminin. Both proteins were present around the periphery of tumour cell islands. In a few cases laminin staining appeared weak and patchy, but as this applied to normal structures as well as to the tumour it was attributed to staining artefact. These findings may have been the result of the method of fixation rather than attributable to a genuine difference in distribution of laminin. Interestingly, the case, in which there was a morphological transition in the tumour from positivity for fibronectin and laminin to absence of fibronectin and laminin staining of consecutive serial sections, suggested that these two proteins were lost simultaneously from the tumour cell margins. A similar phenomenon was observed in a leiomyosarcoma from the ileum.23 These findings resemble the simultaneous loss of fibronectin, laminin, and heparan sulphate proteoglycan from the surfaces of cultured rat kidney cells after viral transformation.27 They suggest that there is a close relation between the expression of fibronectin and laminin. The parallel microanatomical distribution of these proteins points to fibronectin as a genuine constituent of basal lamina. It has been clearly shown that it is not exclusively associated with interstitial collagen, fibronectin being found in sites where interstitial collagen is absent.'3 20 23 The differing distribution of fibronectin and laminin in invasive ductal carcinoma of the breast may nevertheless be explained by increased production of fibronectin, together with interstitial collagen, while basal lamina material is progressively lost. Differing interpretations of the relation of fibronectin around invasive carcinoma to stroma or tumour cells may account for discrepancies in the reported distribution of fibronectin in breast cancer. 1420 28 Stampfer et al reported the presence of fibronectin around the entire external surface of infiltrating breast carcinoma cells, with the exception of an undifferentiated carcinoma from which it was absent.29 Labat-Robert et al described loss of fibronectin from carcinoma cell membranes and partial loss in dysplasia.30 Similar discrepant observations have been recorded on cells cultured from breast cancer in man.293 '32 The distribution of laminin in ductal breast carcinomas noted in this study accords with -other reports, although no intracytoplasmic laminin was shown.33 -35 Discontinuous basement membrane laminin around intraductal breast carcinoma has been observed previously,34 35 and this was seen in one case in the present investigation. The importance of this finding with regard to tumour invasion remains to be determined. Laminin was only seen intracellularly in two of the sixteen adenoid cystic carcinomas studied, one from the breast and one from a submandibular gland. In both cases cytoplasmic staining was focal only and possibly related to excessive production of basal lamina.
ADENOID CYSTIC CARCINOMAS OF BREAST
We conclude that immunostaining for fibronectin and laminin is worthwhile to help make the distinction between genuine adenoid cystic carcinomas and morphologically similar tumours. 
